Literature DB >> 24300886

Molecular epidemiology of hepatitis C virus genotypes and subtypes among injecting drug users in Hungary.

B Tresó1, M Takács, Á Dencs, M Dudás, A Pár, E Rusvai.   

Abstract

The aim of this study was to determine the geographical distribution of hepatitis C virus genotypes/subtypes among people who inject drugs (PWID) recruited at 22 needle exchange sites and drug outpatient services in all seven Planning and Statistical Regions of Hungary. Of 198 such PWID, 147 (74.2%), 45 (22.7%) and six (3.0%) carried genotype 1, 3 or 4, respectively, and 31 (72.1%) of the 43 genotype 1 sequences were of subtype 1a. Genotype 3 was significantly more prevalent in provincial towns than in the capital, Budapest. Injecting for a longer period and an older age both correlated with a higher prevalence of genotype 3, suggesting possible future changes in genotype distribution. The distributions of hepatitis C virus genotypes/ subtypes differed significantly between the tested PWID and the general population. The identification of genotype 3 reflected its worldwide occurrence among PWID. Our results underline the importance of genotyping before treatment, especially among people who have ever injected drugs in Hungary.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24300886     DOI: 10.2807/1560-7917.es2013.18.47.20639

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  5 in total

1.  Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.

Authors:  Josefine Ederth; Camilla Jern; Helené Norder; Lars Magnius; Erik Alm; Björg Kleverman Rognsvåg; Carl-Gustaf Sundin; Mia Brytting; Joakim Esbjörnsson; Mattias Mild
Journal:  Infect Ecol Epidemiol       Date:  2016-02-05

2.  Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.

Authors:  Nunzia Sanarico; Stefania D'Amato; Roberto Bruni; Claudia Rovetto; Emanuela Salvi; Patrizia Di Zeo; Paola Chionne; Elisabetta Madonna; Giulio Pisani; Angela Costantino; Michele Equestre; Maria E Tosti; Alessandra Cenci; Maria T Maggiorella; Leonardo Sernicola; Emanuele Pontali; Alfredo Pansera; Rocco Quattrocchi; Sergio Carbonara; Fabio Signorile; Lorenzo Antonio Surace; Guido Federzoni; Elisa Garlassi; Giulio Starnini; Roberto Monarca; Sergio Babudieri; Maria Rapicetta; Maria G Pompa; Anna Caraglia; Barbara Ensoli; Anna R Ciccaglione; Stefano Buttò
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

3.  Intravenous drug use - an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients.

Authors:  Dubravka Salemovic; Ivana Pesic-Pavlovic; Djordje Jevtovic; Ksenija Bojovic; Jovan Ranin; Branko Brmbolic; Maja Stanojevic
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

4.  Hepatitis C Screening and Treatment Program in Hungarian Prisons in the Era of Direct Acting Antiviral Agents.

Authors:  Klára Werling; Béla Hunyady; Mihály Makara; Krisztina Nemesi; Gábor Horváth; Ferenc Schneider; Judit Enyedi; Zsófia Müller; Miklós Lesch; Zoltán Péterfi; Tamás Tóth; Judit Gács; Zsuzsanna Fehér; Eszter Ujhelyi; Emese Molnár; Anna Nemes Nagy
Journal:  Viruses       Date:  2022-02-02       Impact factor: 5.048

Review 5.  Epidemiology of HCV infection in the Central European region.

Authors:  Petr Urbánek; Pavol Kristian; Michael Makara; Bela Hunyady; Krzysztof Tomasiewicz
Journal:  Clin Exp Hepatol       Date:  2016-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.